Keyword: Ferring Pharmaceuticals
The financing, which could grow by another $1.2 billion, sets Blackstone up to continue placing bets such as its ventures with Novartis and Ferring.
A new gene therapy spinout has nabbed Ipsen chief executive David Meek to help sell its new drug.
The two organizations have put up $570 million to support the spinout as it works to bring the bladder cancer drug to the U.S. and other markets.
Intellia clinical head to be Casebia’s first CMO; Ferring CSO to take over for retiring board president; and Harpoon names new CFO and CSO.
Ferring Pharmaceuticals’ chief operating officer and president of its executive board, Michel Pettigrew, announced that he plans to retire Dec. 31.
Ferring sees the deal as an R&D acquisition that will keep delivering beyond the "front-runner project."
Ferring Pharmaceuticals is funding development of a long-duration peptide drug based on Foresee’s delivery technology.
Ferring Pharmaceuticals has secured the rights to a Phase III treatment of radicular leg pain outside of Japan from Seikagaku.